Anthony Haynes, Managing Director and Greig Pollard, Head of Automation UK
Anthony Haynes, Managing Director and Greig Pollard, Head of Automation UK

Image source: MolGen

Laboratory equipment

MolGen opens new UK office

DNA / RNA extraction technology, system, products and kits for human and animal diagnostics, agriculture, aquaculture, pharma and biotech solutions provider MolGen B.V., announces the recent opening of its UK office.

The new office is located at 6th Floor, South Quay Building, 189 Marsh Wall, London, E14 9SH. This expansion will enable the company to meet the rapidly increasing demand for cost-efficient, high quality diagnostic services in new markets. The new location will serve as a pivotal branch to provide professional laboratories based in London and the UK with access to MolGen’s extraction DNA / RNA portfolio across diagnostics, pharma and the biotech industry. The opening of this new office comes shortly after MolGen opened its US office in San Diego.

We see this new office as a way to further advance the testing and diagnostics industry and provide solutions as to how the world responds to disease and other life science conditions

Niels Kruize

“We have been fortunate to experience such rapid growth as a company. Our ability to scale quickly has been a great asset as we continue to strive to meet the growing demand for our innovations. We see this new office as a way to further advance the testing and diagnostics industry and provide solutions as to how the world responds to disease and other life science conditions,” said Niels Kruize, MolGen CCO. 

Photo

Image source: MolGen

MolGen UK will serve as the launch point for MolGen’s product MegaPrep – a bi-weekly, non-invasive monitoring PCR test that gives users the ability to analyse up to a million samples a day. Using more devices that can be customised to each lab, MegaPrep brings precision, speed and quality to the diagnostics workflow, resulting in accurate analysis at scale. As a pay-by-sample testing method it will help more parts of society, such as schools and business to remain open and combat disease, the company reports. With MegaPrep, MolGen UK strives to forge the future of testing capacity by extending the workflow with monitoring that involves low cost, high-frequency testing and delivers peace of mind to all. 


Source: MolGen B.V.

30.11.2021

Read all latest stories

Related articles

Photo

Sponsored • DNA extraction chemistry

Providing innovative molecular workflows to empower future diagnostics

Founded in 2018 as a DNA extraction chemistry company, Dutch company MolGen entered the market operating within the agricultural sector. At first, the company’s founders, Maarten de Groot, Wim van…

Photo

Abbott cardiovascular

An increasingly dynamic cardiovascular presence

In the world of laboratory diagnostics, ‘Abbott’ is a household name. Few people however are aware of the fact that the company, headquartered in Illinois, USA, is also leading in other fields. A…

Photo

Collaboration

Partnership to enhance pharma drug development and single cell research

Olympus and Cytosurge AG, developer of the disruptive and patented FluidFM technology, announced their collaboration to significantly expand the awareness and availability of the FluidFM BOT* – a…

Related products

MolGen – PurePrep 96

Extraction

MolGen – PurePrep 96

MolGen
MolGen - PurePrep FR

Sample processing

MolGen - PurePrep FR

MolGen
MolGen - PurePrep TTR

Sample processing

MolGen - PurePrep TTR

MolGen
Dürr Technik – Sicolab – compressor stations

Compressors

Dürr Technik – Sicolab – compressor stations

Dürr Technik GmbH & Co. KG
Subscribe to Newsletter